- Accesswire•5 days ago
VANCOUVER, BC / ACCESSWIRE / February 14, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the " Company ") is announcing today that it will be seeking to adjourn its upcoming annual ...
- Marketwired•10 days ago
CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Inc. and the role the company's ...
- Accesswire•16 days ago
VANCOUVER, BC / ACCESSWIRE / February 3, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (" ATT " or the " Company ") announces that it is completing work on its audit and ...
ATTBF : Summary for ABATTIS BIOCEUTICALS - Yahoo Finance
Abattis Bioceuticals Corp. (ATTBF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.17 - 0.19|
|52 Week Range||0.01 - 1.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|